Literature DB >> 11215734

Role of mucus reduction and luminal acid elevation in increased susceptibility of stomach to nonsteroidal antiinflammatory drug-induced injury in arthritic rats.

K Okuyama1, M Jinbo, N Saito, S Igarashi, H Narita, M Kinoshita.   

Abstract

We investigated the role of gastric mucus and acid secretion in the increase of nonsteroidal antiinflammatory drug-induced gastric lesions in adjuvant-induced arthritic rats. Both aspirin- and indomethacin-induced gastric injury were remarkably worsened in the arthritic rats. In the arthritic rats, the amounts of mucus glycoprotein in both the mucosa and adherent gel layer were respectively decreased to 70% and 34% of those in normal rats, while gastric acid secretion was augmented to 1.5-fold. The gastroprotective antiulcer agent ecabet sodium, which increased the mucus content in the gel layer but did not affect the luminal acid contents, prevented the increase of both lesions induced by aspirin and indomethacin. Cimetidine also inhibited the formation of aspirin- and indomethacin-induced damage as well as the acid secretion in the arthritic rats. In conclusion, an imbalance between gastric defensive and aggressive systems due to the loss of adherent mucus glycoprotein and the elevation of the luminal acid contents seems to account for the increased susceptibility of the lesion-inducing properties of nonsteroidal antiinflammatory drugs in arthritic rats.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11215734     DOI: 10.1023/a:1026431623485

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  Effects of ecabet sodium, a novel gastroprotective agent, on mucin metabolism in rat gastric mucosa.

Authors:  T Ichikawa; K Ishihara; H Hayashida; H Hiruma; K Saigenji; K Hotta
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

Review 2.  Review article: new insights into prostaglandins and mucosal defence.

Authors:  J L Wallace; A W Tigley
Journal:  Aliment Pharmacol Ther       Date:  1995-06       Impact factor: 8.171

3.  Changes in gastric mucosal ulcerogenic responses in rats with adjuvant arthritis: role of nitric oxide.

Authors:  S Kato; A Tanaka; T Kunikata; M Nishijima; K Takeuchi
Journal:  Aliment Pharmacol Ther       Date:  1999-06       Impact factor: 8.171

Review 4.  Experimental pathogenesis: drugs and chemical lesions in the gastric mucosa.

Authors:  S Szabo; I Goldberg
Journal:  Scand J Gastroenterol Suppl       Date:  1990

5.  Luminal surface hydrophobicity of canine gastric mucosa is dependent on a surface mucous gel.

Authors:  P J Goddard; Y C Kao; L M Lichtenberger
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

6.  Correlation of quantitative changes of gastric mucosal glycoproteins with aspirin-induced gastric damage in rats.

Authors:  Y Azuumi; S Ohara; K Ishihara; H Okabe; K Hotta
Journal:  Gut       Date:  1980-06       Impact factor: 23.059

7.  Guidelines for the management of rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines.

Authors: 
Journal:  Arthritis Rheum       Date:  1996-05

8.  Molecular weight of gastric mucus glycoprotein is a determinant of the degree of subsequent aspirin induced chronic gastric ulceration in the rat.

Authors:  P F Bagshaw; D J Munster; J G Wilson
Journal:  Gut       Date:  1987-03       Impact factor: 23.059

9.  Altered susceptibility of arthritic rats to the gastric lesion-inducing effects of aspirin or ethanol and the antilesion effect of rioprostil.

Authors:  L B Katz; T Genna; B L Fuller; E L Tolman; D A Shriver
Journal:  Agents Actions       Date:  1987-10

10.  THE ESTIMATION OF PEPSIN, TRYPSIN, PAPAIN, AND CATHEPSIN WITH HEMOGLOBIN.

Authors:  M L Anson
Journal:  J Gen Physiol       Date:  1938-09-20       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.